References
- Alwayn IP, Gura K, Nosé V, 2005. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 57:445–452.
- Alonso A, Ruiz-Gutierrez V, Martinez-Gonzalez MA. 2006. Monounsaturated fatty acids, olive oil and blood pressure: Epidemiological, clinical and experimental evidence. Public Health Nutr 9:251–257.
- Angulo P. 2002. Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231.
- Assy N, Nassar F, Nasser G, Grosovski M. 2009. Olive oil consumption and non-alcoholic fatty liver disease. World J Gastroenterol 15:1809–1815.
- Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, 2002. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123:134–140.
- Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, Svegliati-Baroni G, Sofi F, Milani S, Abbate R, 2006. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 23:1143–1151.
- Hussein O, Grosovski M, Lasri E, Svalb S, Ravid U, Assy N, 2007. Monounsaturated fat decrease hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol 13:361–368.
- Lee S, Gura Km, Puder M. 2007. Omega-3 fatty acids and liver disease. Hepatology 45:841–845.
- Lizardi-Cervera J, Aguilar-Zapata D. 2009. Nonalcoholic fatty liver disease and its association with cardiovascular disease. Ann Hepatol 8:S40–S43.
- Moscatello S, Marzocchi R, Villanova N. 2008. Which treatment for nonalcoholic fatty liver disease? Mini Rev Med Chem 8:767–775.
- Oh MK, Winn J, Poordad F. 2008. Review article: Diagnosis and treatment of non-alcoholic fatty liver disease. Aliment Pharmacol Ther 28:503–522.
- Paniagua JA, Gallego de la Sacristana A, Romero I, Vidal-Puig A, Latre JM, Sanchez E, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F. 2007. Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care 30:1717–1723.
- Spadaro L, Magliocco O, Spampanato D, Piro S, Oliveri C, Alagona C, Papa G, Rabuazzo AM, Purrello F. 2008. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 40:194–199.
- Svegliati-Baroni G, Candelaresi C, Saccomanno S, Ferretti G, Bachetti T, Marzioni M, De Mincis S, Nobili L, Salzano R, Omenetti A, Pacetti D, 2006. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 169:846–860.
- Wieckowska A, McCullough AJ, Feldstein AE. 2007. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 46:582–589.
- Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DM. 2008. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol 14:6395–6400.